QQQ $ 601.86 $ 4.22 (0.71 %)
DIA $ 462.77 $ 0.00 (0 %)
SPY $ 664.95 $ 2.94 (0.44 %)
TLT $ 90.78 $ -0.20 (-0.22 %)
GLD $ 387.30 $ 6.60 (1.73 %)
$ 0.16
-- x --
-- x --
-- - --
$ 0.06 - $ 0.19
282,531
na
4.69M
$ 2.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-15-2025 12-31-2024 10-K
4 11-26-2024 09-30-2024 10-Q
5 08-19-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 04-03-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-20-2019 03-31-2019 10-Q
27 04-16-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-21-2018 03-31-2018 10-Q
31 04-17-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-21-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-10-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
39 03-29-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 windtree-therapeutics-terminates-seismic-c-clinical-study-at-20-enrollments-termination-due-to-limited-resources-not-safety-concerns

-SEC Filing

 windtree-therapeutics-performs-planned-interim-analysis-of-seismic-c-phase-2-study-data-evaluating-istaroxime-in-scai-stage-c-cardiogenic-shock

Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and...

 why-are-public-companies-amassing-eth-xrp-sol-bnb-instead-of-just-bitcoin

Publicly traded companies are increasingly integrating cryptocurrencies other than Bitcoin (CRYPTO: BTC), into their treasuries...

 windtree-enters-into-common-stock-purchase-agreement-for-up-to-500m-to-establish-equity-line-of-credit-and-bolster-bnb-cryptocurrency-treasury-strategy

Up to $700 Million Committed to BNB Acquisitions, Reinforcing Innovative Crypto Treasury StrategyNinety Nine Percent of the pro...

 windtree-therapeutics-announces-up-to-520m-in-new-funding-for-its-cryptocurrency-treasury-strategy

Up to $700 Million Committed to BNB Acquisitions, Reinforcing Innovative Crypto Treasury StrategyNinety Nine Percent of the pro...

 windtree-therapeutics-partners-with-kraken-to-provide-custody-trading-and-over-the-counter-services-for-windtrees-bnb-crypto-treasury-strategy

Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT) is pleased to announce a strategic p...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION